[The effect of piracetam on lipid peroxidation in the rat brain]. 1990

L Benov, and V Markova, and Ia Todorova, and G Krysteva

The effect of piracetam on lipid peroxidation (LPO) in the rat brain was investigated. Piracetam was shown not to catalyze LPO and not to stimulate production of active forms of oxygen but to increase LPO only in the presence of traces of transition of metal ions. In all probability, the reason of this is the capacity of piracetam to chelate these metals. In this case their catalytic activity with respect to LPO increases. The performed studies demonstrate that the observed increase in LPO in the rat brain during the use of piracetam is an artefact due to the presence of traces of transition metal ions.

UI MeSH Term Description Entries
D007502 Iron Chelating Agents Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. Iron Chelates,Agents, Iron Chelating,Chelates, Iron,Chelating Agents, Iron
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D010889 Piracetam A compound suggested to be both a nootropic and a neuroprotective agent. 2-Pyrrolidone-N-Acetamide,Avigilen,Axonyl,Cerebroforte,Cerepar N,Ciclofalina,Cuxabrain,Dinagen,Gabacet,Geram,Memo-Puren,Nootrop,Nootropil,Nootropyl,Normabraïn,Piracebral,Piracetam AbZ,Piracetam-RPh,Piracetrop,Pirazetam,Pyracetam,Pyramem,Sinapsan,UCB-6215,Memo Puren,Piracetam RPh,UCB 6215,UCB6215
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

L Benov, and V Markova, and Ia Todorova, and G Krysteva
January 1981, Experientia,
L Benov, and V Markova, and Ia Todorova, and G Krysteva
April 1985, British journal of experimental pathology,
L Benov, and V Markova, and Ia Todorova, and G Krysteva
January 1982, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
L Benov, and V Markova, and Ia Todorova, and G Krysteva
March 1994, Neurochemical research,
L Benov, and V Markova, and Ia Todorova, and G Krysteva
October 1982, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
L Benov, and V Markova, and Ia Todorova, and G Krysteva
February 1997, Neurochemistry international,
L Benov, and V Markova, and Ia Todorova, and G Krysteva
March 1995, Neuroreport,
L Benov, and V Markova, and Ia Todorova, and G Krysteva
January 1997, Biofizika,
L Benov, and V Markova, and Ia Todorova, and G Krysteva
August 1961, Canadian journal of biochemistry and physiology,
L Benov, and V Markova, and Ia Todorova, and G Krysteva
January 2002, Pharmacology & toxicology,
Copied contents to your clipboard!